Suchergebnisse - "Malathum, Kumthorn"

PubPharm (81)

1

Impact of removing ESBL testing report from cultures on the selection of antibiotics for the treatment and 30-day mortality of patients infected with ESBL-producing organisms

enthalten in: ResearchSquare.com | 2024

von Waeuseng, S. | Kiertiburanakul, S. | Malathum, K.

2

Immunogenicity of Intradermal Versus Intramuscular BNT162b2 COVID-19 Booster Vaccine in Patients with Immune-Mediated Dermatologic Diseases : A Non-Inferiority Randomized Controlled Trial

enthalten in: Vaccines | 2024

von Seree-Aphinan, C. | Rattanakaemakorn, P. | Suchonwanit, P. | +10

3

Epidemiology of extended-spectrum β-lactamase-producing Enterobacterales infection in kidney transplant recipients

enthalten in: Antimicrobial resistance and infection control | 2023

von Promsuwan, O. | Malathum, K. | Ingsathit, A.

4

Epidemiology of extended-spectrum β-lactamase–producing Enterobacterales infection in kidney transplant recipients

enthalten in: Antimicrobial resistance and infection control | 2023

von Promsuwan, O. | Malathum, K. | Ingsathit, A.

5

SARS-CoV-2-specific Humoral and Cell-mediated Immune Responses after Immunization with Inactivated COVID-19 Vaccine in Kidney Transplant Recipients (CVIM 1 Study)

enthalten in: bioRxiv.org | 2023

von Bruminhent, J. | Sethaudom, C. | Chaumdee, P. | +10

6

An additional dose of viral vector COVID-19 vaccine and mRNA COVID-19 vaccine in kidney transplant recipients : A randomized controlled trial (CVIM 4 study)

enthalten in: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons | 2022

von Bruminhent, J. | Setthaudom, C. | Phornkittikorn, P. | +12

7

Durability of Humoral and Cellular Immunity after an Extended Primary Series with Heterologous Inactivated SARS-CoV-2 Prime-Boost and ChAdOx1 nCoV-19 in Dialysis Patients (ICON3)

enthalten in: Vaccines | 2022

von Boongird, S. | Setthaudom, C. | Kitpermkiat, R. | +9

8

Detectable Duration of Viable SARS-CoV-2, Total and Subgenomic SARS-CoV-2 RNA in Noncritically Ill COVID-19 Patients : a Prospective Cohort Study

enthalten in: Microbiology spectrum | 2022

von Phuphuakrat, A. | Pasomsub, E. | Srichatrapimuk, S. | +13

9

Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients

enthalten in: Scientific reports | 2022

von Bruminhent, J. | Setthaudom, C. | Kitpermkiat, R. | +10

10

SARS-CoV-2-specific humoral and cell-mediated immune responses after immunization with inactivated COVID-19 vaccine in kidney transplant recipients (CVIM 1 study)

enthalten in: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons | 2022

von Bruminhent, J. | Setthaudom, C. | Chaumdee, P. | +11

1
2
3
4
5
6
7
8
9
Nächster »
[9]